Gene · 54210
Papers3,294
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,294
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of DAP12 in immune-related inflammatory diseases. | Inflamm Res | 2026 | 42089995 | PubTator, text mining | PubMed |
| A NETs-centric multi-omics framework prioritizes PGLYRP1 and MMP9 as subtype-associated thromboinflammatory biomarker candidates and putative therapeutic hypotheses in ischemic stroke. | Neurobiol Dis | 2026 | 42066918 | PubTator, text mining | PubMed |
| Predicting referral need for febrile children in low-resource community settings in South and Southeast Asia. | Nat Med | 2026 | 42056495 | PubTator, text mining | PubMed |
| Single-cell analysis reveals crosstalk between TREM1-positive myeloid cells and cancer-associated fibroblasts in colorectal cancer progression. | J Gastroenterol | 2026 | 42045486 | PubTator, text mining | PubMed |
| Collagen-Enriched Immunomodulatory Hydrogel for Tendon Regeneration. | Gels | 2026 | 42042155 | PubTator, text mining | PubMed |
| Integrating bulk, single-cell, and spatial transcriptomics to identify a novel pyroptosis-related gene signature for predicting prognosis and tumor immune landscape in triple-negative breast cancer. | Front Immunol | 2026 | 42023218 | PubTator, text mining | PubMed |
Soluble triggering receptor expressed on myeloid cells-1 as a predictive biomarker in sepsis: insights into cut-offs, mortality risk, and treatment guidance-secondary analysis of the Next GeneSiS-Trial. | Crit Care | 2026 | 42015279 | PubTator, text mining | PubMed |
| TREM-1-Associated Neutrophil Extracellular Trap Formation is Linked to IVIG Resistance in Kawasaki Disease: A Convergent Transcriptomic and Prospective Validation Study. | J Clin Immunol | 2026 | 42010185 | PubTator, text mining | PubMed |
| COVID-19 vaccination shifts neutrophils toward a mixed activated and regulatory phenotype in patients with severe disease. | Mol Biol Rep | 2026 | 41964802 | PubTator, text mining | PubMed |
| Sphingolipid-associated signature unveils TIMP1-driven temozolomide resistance and guides stratified therapy in glioblastoma. | Front Immunol | 2026 | 41929516 | PubTator, text mining | PubMed |
| The role of the triggering receptor expressed on myeloid cells family in metabolic syndrome: A review. | Cell Signal | 2026 | 41916487 | PubTator, text mining | PubMed |
| CSF1 regulates inflammation and apoptosis in intervertebral disc degeneration. | Sci Rep | 2026 | 41912624 | PubTator, text mining | PubMed |
| Role of triggering receptor expressed on Myeloid Cells-1 (TREM-1) in the prognostic evaluation in bacterial endophthalmitis. | Exp Eye Res | 2026 | 41905707 | PubTator, text mining | PubMed |
| Current Insights into Clinical, Molecular, and Therapeutic Approaches to Acute Respiratory Distress Syndrome. | Med Sci (Basel) | 2026 | 41892849 | PubTator, text mining | PubMed |
| Immunotherapies for Ischemic Stroke Patients: Current Status and Future Directions. | Med Sci (Basel) | 2026 | 41892826 | PubTator, text mining | PubMed |
| Immunomodulatory Tissue-Engineering Strategies for Diabetic Foot Ulcer Management: A Systematic Review. | Wound Repair Regen | 2026 | 41879138 | PubTator, text mining | PubMed |
| Peptidoglycan recognition proteins in the brain: Role in neuroinflammation and behavioral consequences. | Histol Histopathol | 2026 | 41869845 | PubTator, text mining | PubMed |
| Trem1 regulates neutrophil metabolism and recruitment in lung ischemia-reperfusion injury. | Redox Biol | 2026 | 41861599 | PubTator, text mining | PubMed |
| TREM1-NLRP3-driven pyroptosis in sepsis-associated acute kidney injury (AKI) with parallel autophagy changes. | Sci Rep | 2026 | 41857115 | PubTator, text mining | PubMed |
Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trial. | Lancet Respir Med | 2026 | 41856148 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54210/papers?page=3